Conviction
$ Value
$500K
Shares
231,482
Price
$2
Filed
Mar 25
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Angel Matthew
Title
CEO and President
CIK
0001931356
Roles
Transaction Details
Transaction Date
2026-03-24
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
231,482
Footnotes
The shares are held by Factor Bioscience Inc. ("Factor"). The Reporting Peron is the chief executive officer and chairman of the board of directors of Factor and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein. | The shares reported herein give effect to the pro rata distributions of shares by Erigen LLC for no additional consideration to its members, subsequent to the Reporting Person's last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distribution of such shares constituted only a change in the form the Reporting Person's ownership in such shares, the Reporting Person was not required to report the distribution pursuant to Section 16.
Filing Info
Other Insiders at TPST (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pellizzari Christine A | — | — | 2026-01-27 |
| NICHOL GEOFFREY | — | — | 2026-01-27 |
| RAAB MICHAEL | — | — | 2026-01-27 |
|
Maestas Nicholas
Chief Financial Officer
|
— | — | 2026-03-31 |
| Simantov Ronit | — | — | 2026-01-27 |
|
Angel Matthew
CEO and President
|
— | — | 2026-02-04 |
|
Trojanowski Justin
Corporate Controller
|
— | — | 2026-03-31 |